{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:40:09Z","timestamp":1794328809687,"version":"4.9.0"},"reference-count":27,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>\n                    Tularemia is a rare zoonotic infection with marked geographic clustering and long interepidemic periods. Pediatric data, particularly those on host immune responses during active disease and treatment, remain scarce. The authors aimed to evaluate clinical characteristics and treatment-associated cytokine dynamics in children with tularemia. In the present multicenter prospective study conducted in T\u00fcrkiye, 40 pediatric patients with laboratory-confirmed tularemia and nine age- and sex-matched healthy controls were enrolled between April 2023 and November 2024. Clinical features, exposure history, and treatment outcomes were recorded. Serum cytokine levels, including interleukin (IL)-6, IL-2, IL-9, IL-5, IL-13, tumor necrosis factor-\u03b1, IL-10, interferon (IFN)-\u03b3, IL-4, and IL-22, were measured using a multiplex bead-based assay and compared between patients and controls, between good and poor outcome groups, and longitudinally before and after therapy. A good outcome was defined as complete clinical resolution without suppuration, the need for surgical intervention, or relapse, whereas a poor outcome was defined as clinical nonresolution or progression. A total of 24 (60%) participants had a good outcome, and 16 (40%) had a poor outcome. Although baseline cytokine levels did not differ between groups, paired analyses revealed significant posttreatment reductions in IFN-\u03b3 (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.018), IL-6 (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.018), and IL-10 (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.032), consistent with resolution of infection-associated immune activation. A poor outcome was associated with increased exposure to natural water sources and a higher frequency of suppurative lymphadenopathy requiring surgical drainage. Baseline cytokine profiles did not predict treatment response; however, dynamic changes in IFN-\u03b3, IL-6, and IL-10 were associated with clinical recovery. These findings highlight the importance of longitudinal immune monitoring and provide insight into immune dynamics in pediatric tularemia.\n                  <\/jats:p>","DOI":"10.4269\/ajtmh.26-0084","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:08:33Z","timestamp":1781204913000},"page":"254-262","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Features, Treatment Outcomes, and Cytokine Levels in Pediatric Tularemia Patients in T\u00fcrkiye"],"prefix":"10.4269","volume":"115","author":[{"given":"Ozlem","family":"Cakici","sequence":"first","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Sivas Numune Hospital, Sivas, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubra","family":"Aykac","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bera Enes","family":"Seyrek","sequence":"additional","affiliation":[{"name":"Hacettepe University School of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail Cem","family":"Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Izmir Biomedicine and Genome Center, DEU Saglik Kampusu, Balcova, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman Oguz","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rem","family":"Evcili","sequence":"additional","affiliation":[{"name":"Izmir Biomedicine and Genome Center, DEU Saglik Kampusu, Balcova, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011f\u00e7e","family":"Canavar Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Izmir Biomedicine and Genome Center, DEU Saglik Kampusu, Balcova, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Izmir Biomedicine and Genome Center, DEU Saglik Kampusu, Balcova, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Hafize","family":"Erdeniz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Ondokuz May\u0131s University Faculty of Medicine, Samsun, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Yasar Durmus","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Kayseri City Hospital, Kayseri, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131han","family":"Sahin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Kahramanmaras Necip Faz\u0131l City Hospital, Kahramanmaras, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevliya","family":"Ocal Demir","sequence":"additional","affiliation":[{"name":"Department of Pediatric Diseases, Marmara University Faculty of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Bulent","family":"Cengiz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayda","family":"G\u00fcrsel","sequence":"additional","affiliation":[{"name":"Izmir Biomedicine and Genome Center, DEU Saglik Kampusu, Balcova, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130hsan","family":"G\u00fcrsel","sequence":"additional","affiliation":[{"name":"Izmir Biomedicine and Genome Center, DEU Saglik Kampusu, Balcova, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Ozsurekci","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Ann NY Acad Sci","first-page":"1","article-title":"Tularemia: History, epidemiology, pathogen physiology, and clinical manifestations","volume":"1105","author":"Sj\u00f6stedt","year":"2007"},{"issue":"2","key":"b2","series-title":"Infect Dis Clin North Am","first-page":"289","article-title":"Tularemia: Current epidemiology and disease management","volume":"20","author":"Eliasson","year":"2006"},{"issue":"1","key":"b3","series-title":"Emerg Infect Dis","first-page":"1","article-title":"Tularemia in children, Turkey, September 2009\u2013November 2012","volume":"21","author":"Tezer","year":"2015"},{"issue":"1","key":"b4","series-title":"Emerg Infect Dis","first-page":"173","article-title":"Diverse Francisella tularensis strains and oropharyngeal tularemia, Turkey","volume":"21","author":"\u00d6zs\u00fcrekci","year":"2015"},{"issue":"2","key":"b5","series-title":"Turk J Pediatr","first-page":"105","article-title":"Tularemia in children: Evaluation of clinical, laboratory and therapeutic features of 27 tularemia cases","volume":"54","author":"Kaya","year":"2012"},{"issue":"1","key":"b6","series-title":"Curr Trop Med Rep","first-page":"12","article-title":"Tularemia in Turkey: Epidemiological challenges and global implications","volume":"12","author":"Ozsurekci","year":"2025"},{"issue":"4","key":"b7","series-title":"Clin Microbiol Rev","first-page":"631","article-title":"Tularemia","volume":"15","author":"Ellis","year":"2002"},{"key":"b8","series-title":"Front Cell Infect Microbiol","first-page":"1679691","article-title":"IFN-\u03b3-Driven macrophage responses in the immunity to Mycobacterium tuberculosis and Mycobacterium leprae.","volume":"15","author":"Imran","year":"2025"},{"key":"b9","series-title":"Int Immunopharmacol","first-page":"109130","article-title":"Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022"},{"issue":"21","key":"b10","series-title":"JAMA","first-page":"2763","article-title":"Tularemia as a biological weapon: Medical and public health management","volume":"285","author":"Dennis","year":"2001"},{"issue":"2","key":"b11","series-title":"Eur Respir J","first-page":"361","article-title":"Tularaemia","volume":"21","author":"T\u00e4rnvik","year":"2003"},{"key":"b12","series-title":"Front Microbiol","first-page":"26","article-title":"Immunity to Francisella.","volume":"2","author":"Cowley","year":"2011"},{"issue":"2","key":"b13","series-title":"Microbes Infect","first-page":"561","article-title":"Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen","volume":"8","author":"Sj\u00f6stedt","year":"2006"},{"key":"b14","series-title":"Front Microbiol","first-page":"1549343","article-title":"The immune response to Francisella tularensis.","volume":"16","author":"Barthels","year":"2025"},{"issue":"2","key":"b15","series-title":"Infect Immun","first-page":"585","article-title":"Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection","volume":"81","author":"Kurtz","year":"2013"},{"issue":"1","key":"b16","series-title":"Clin Immunol","first-page":"27","article-title":"The effects of IL-6 on CD4 T cell responses","volume":"130","author":"Dienz","year":"2009"},{"issue":"4","key":"b17","series-title":"Mol Immunol","first-page":"677","article-title":"Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice","volume":"46","author":"Zhang","year":"2009"},{"issue":"12","key":"b18","series-title":"Mol Immunol","first-page":"3428","article-title":"Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFN\u03b3 response","volume":"45","author":"Parsa","year":"2008"},{"issue":"10","key":"b19","series-title":"PLoS Pathog","first-page":"e1006630","article-title":"IFN-\u03b3 extends the immune functions of Guanylate Binding Proteins to inflammasome-independent antibacterial activities during Francisella novicida infection","volume":"13","author":"Wallet","year":"2017"},{"issue":"3","key":"b20","series-title":"Nat Rev Immunol","first-page":"170","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010"},{"issue":"1","key":"b21","series-title":"Sci Data","first-page":"329","article-title":"Systematic analysis of infectious disease outcomes by age shows lowest severity in school-age children","volume":"7","author":"Glynn","year":"2020"},{"issue":"1","key":"b22","series-title":"Emerg Microbes Infect","first-page":"1027","article-title":"Tularemia as a waterborne disease: A review","volume":"8","author":"Hennebique","year":"2019"},{"issue":"12","key":"b23","series-title":"Emerg Infect Dis","first-page":"2213","article-title":"Water as source of Francisella tularensis infection in humans, Turkey","volume":"21","author":"Kilic","year":"2015"},{"issue":"1","key":"b24","series-title":"Balkan Med J","first-page":"3","article-title":"Epidemiology of tularemia","volume":"31","author":"G\u00fcrcan","year":"2014"},{"key":"b25","series-title":"Clin Infect Dis","first-page":"S29","article-title":"Tularemia clinical manifestations, antimicrobial treatment, and outcomes: An analysis of US surveillance data, 2006\u20132021","volume":"78","author":"Wu","year":"2024"},{"issue":"5","key":"b26","series-title":"Turk J Pediatr","first-page":"554","article-title":"Suppurative cervical adenopathy and pharyngeal mass due to tularemia unresponsive to medical treatment","volume":"53","author":"Ozs\u00fcrekci","year":"2011"},{"key":"b27","series-title":"Front Microbiol","first-page":"1348323","article-title":"Tularemia treatment: Experimental and clinical data","volume":"14","author":"Maurin","year":"2024"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/115\/2\/article-p254.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/115\/2\/article-p254.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/115\/2\/article-p254.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:10:39Z","timestamp":1785935439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/115\/2\/article-p254.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":27,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.26-0084","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}